Unilever Exiting OTC Diagnostics Business With Unipath Sale
This article was originally published in The Tan Sheet
Executive Summary
Unilever plans to divest its nearly $90 mil. Unipath women's health diagnostics business, which includes the Clearblue line of home pregnancy test kits, to focus on selected consumer brands, the firm said June 19.